Skip to main content
. 2008 Oct 28;14(40):6154–6162. doi: 10.3748/wjg.14.6154

Figure 1.

Figure 1

Distribution of Fibroscan values in Blood donors (Controls), Inactive carriers without (True I.C.) or with dysmetabolic liver disease (I.C. with LD) and in CHB patients by fibrosis stage (S0-S2, S3-S4, S5-S6, US Cirrhosis).